Wellthera Co., Ltd. was founded in 2018 to translate academic innovation into real-world medical solutions, addressing unmet medical needs in drug delivery.

Originating from research conducted at the Laboratory of Drug and Gene  Delivery Research, Faculty of Pharmaceutical Sciences, Teikyo University, Wellthera is built on pioneering work led by Professor Emeritus Kazuo Maruyama, Professor Ryo Suzuki, and Lecturer Daiki Omata.
Professor Maruyama currently serves as Professor in Theranostics Laboratory, Faculty of Pharmaceutical Sciences, Teikyo University.

With BUS-DDS (Bubble Ultrasound-mediated Drug Delivery System) as its core technology, Wellthera is developing non-invasive, localized drug delivery solutions for tissues that remain difficult to treat with conventional approaches.

The Laboratory of Drug and Gene Delivery Reserch　https://www.teikyo-dds.com/

Theranostics Laboratory　https://teikyo-dds-lab1.jimdoweb.com/